Patents Assigned to Arissa Pharma Ltd.
  • Publication number: 20170216305
    Abstract: The present invention is directed to a method of administering a meloxicam formulation to a mammalian subject in need thereof including: orally administering to the subject an oral solid dosage form including an amorphous meloxicam-cyclodextrin inclusion complex, where administering the amorphous meloxicam-cyclodextrin inclusion complex results in the subject achieving a Tmax not greater than about 3.0 hours.
    Type: Application
    Filed: September 29, 2015
    Publication date: August 3, 2017
    Applicant: Arissa Pharma Ltd.
    Inventors: Hong Sun, Yan Hu, Yansheng Chen, Luwei Zhao